PubRank

Jan Dürig

Author PubWeight™ 42.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2008 2.58
2 CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003 1.99
3 Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 2006 1.89
4 Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. Cancer Cell 2013 1.68
5 A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 2009 1.48
6 Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012 1.40
7 Revision of the human hematopoietic tree: granulocyte subtypes derive from distinct hematopoietic lineages. Cell Rep 2013 1.30
8 Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia. Blood 2011 1.24
9 HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2004 1.10
10 Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 2014 1.06
11 Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway. Mol Cancer Ther 2010 1.03
12 Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs. Onkologie 2010 0.98
13 The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia. Clin Cancer Res 2006 0.98
14 CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol Dial Transplant 2008 0.96
15 Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany. Ann Hematol 2011 0.95
16 Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2006 0.93
17 Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab. Histochem Cell Biol 2011 0.93
18 CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia. Blood 2013 0.92
19 Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia. Br J Haematol 2007 0.92
20 Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition. Cancer Genet Cytogenet 2009 0.90
21 Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol 2009 0.89
22 Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype. Cancer Immunol Immunother 2013 0.88
23 Telomeres and prognosis in patients with chronic lymphocytic leukaemia. Int J Hematol 2011 0.88
24 Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 2012 0.88
25 BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia. Leuk Lymphoma 2009 0.85
26 Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study. Ann Hematol 2013 0.85
27 Gene dosage effects in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010 0.83
28 Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model. Eur J Haematol 2011 0.82
29 Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. Am J Hematol 2014 0.81
30 A patient without monocytes who had pulmonary renal syndrome. Am J Kidney Dis 2004 0.80
31 Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia. Leuk Res 2008 0.80
32 Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migration. Int J Biochem Cell Biol 2012 0.80
33 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. Eur J Haematol 2004 0.80
34 B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors. Leuk Lymphoma 2004 0.79
35 Prognostic significance of molecular remission in follicular lymphoma. J Clin Oncol 2010 0.78
36 Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia. PLoS One 2013 0.78
37 p53 protein expression in chronic lymphocytic leukemia. Leuk Lymphoma 2012 0.78
38 Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia. Br J Haematol 2008 0.78
39 The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia. Leuk Lymphoma 2003 0.77
40 FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. Eur J Haematol 2009 0.77
41 Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia. Int J Hematol 2015 0.75
42 CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms. Leuk Res 2012 0.75
43 Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages. Stem Cell Reports 2015 0.75